Surgery Partners Receivables

Surgery Partners (SGRY) currently reports a receivables of $620M as of June 2026. That compares with $560M in the prior-year period — up 9.5% year over year. Use the charts on this page to explore Surgery Partners's receivables history and peer comparisons.

Surgery Partners's receivables increased from $560M to $620M — a 9.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surgery Partners reported $620M in receivables as of June 2026. That compares with $560M in the prior-year period — up 9.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $620M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Surgery Partners, and consider following SGRY for alerts when major investors trade the stock.

Surgery Partners is classified in the Healthcare sector. On receivables, it currently shows $620M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SGRY with unrelated industries.